Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 100/100

Failure Rate

66.7%

2 terminated/withdrawn out of 3 trials

Success Rate

33.3%

-53.2% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed trials have results

Key Signals

Enrollment Performance

Analytics

No phase data available

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (3)

Showing 3 of 3 trials
NCT06514183Terminated

Eumycetoma Long-term Post-Treatment Follow-Up Study

Role: collaborator

NCT04207645Terminated

Modification and Validation of the RIPASA Score for Diagnosis of Acute Appendicitis

Role: lead

NCT03185637Completed

Children's Surgery in Sub-Saharan Africa

Role: collaborator

All 3 trials loaded